Skip to content

Deep Tech & Strategic

Pharma & Biotech

FDA 21 CFR Part 11, EU Annex 11, GxP, 20-year molecule IP

Twenty-year molecule IP under GxP is confidentiality your current cryptography cannot promise.

What's exposed in a pharma estate

critical

20-year molecule IP

Confidentiality longer than any deployed algorithm.

warn

GxP record integrity

Signatures for regulated records.

warn

Clinical-data confidentiality

Patient and trial data under DPDP/HIPAA.

Your product set

Every product that applies here.

3 shipping now · 19 total

Frameworks for this sector

FDA 21 CFR Part 11EU Annex 11DPDP 2023NIST IR 8547

Migration sequence

  1. 01First 90 days90 days
    discovercomply
  2. 02First year12 months
    certussignvault
  3. 03Multi-yearmulti-year
    orchestratecustody

Sector FAQ

Where do we start in pharma?
Every engagement starts with Discover, a crypto inventory and CBOM. You cannot migrate what you cannot see, and even at stage one you leave with a CBOM.
Do you replace our existing tools?
No. Dhiti runs on the SIEM, EDR and scanners you already own, and adds the cryptographic layer none of them cover.

Get started

Map the exposure in your pharma estate.